← Back to federal legislation
H.R. 2821Passed House

FDA Modernization Act 3.0

Introduced: Apr 10, 2025

Latest action date: Jul 21, 2026

Latest development

Received in the Senate.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Apr 10, 2025
Recorded roll calls
0

Status detail: The full action history records passage in the House.

Plain-language overview

What this bill does

We’re still gathering this summary

This information hasn’t been synced from Congress.gov yet. Follow this bill and we’ll prioritize it for an upcoming sync.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

View 5 official legislative subjects
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationMedical researchResearch administration and funding

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 10, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline18 actions
  1. Received in the Senate.

    IntroReferralSenate
  2. Motion to reconsider laid on the table Agreed to without objection.

    FloorHouse floor actions
  3. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)

    FloorLibrary of Congress
  4. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)

    FloorHouse floor actions
  5. DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.

    FloorHouse floor actions
  6. Considered under suspension of the rules. (consideration: CR H4639-4640)

    FloorHouse floor actions
  7. Mr. Guthrie moved to suspend the rules and pass the bill.

    FloorHouse floor actions
  8. Reported by the Committee on Energy and Commerce. H. Rept. 119-706.

    CommitteeHouse floor actions
  9. Reported by the Committee on Energy and Commerce. H. Rept. 119-706.

    CommitteeLibrary of Congress
  10. Placed on the Union Calendar, Calendar No. 614.

    CalendarsHouse floor actions
  11. Ordered to be Reported by the Yeas and Nays: 44 - 0.

    CommitteeHouse committee actions
  12. Committee Consideration and Mark-up Session Held

    CommitteeHouse committee actions
  13. Subcommittee Consideration and Mark-up Session Held

    CommitteeHouse committee actions
  14. Forwarded by Subcommittee to Full Committee by Voice Vote.

    CommitteeHouse committee actions
  15. Referred to the Subcommittee on Health.

    CommitteeHouse committee actions
  16. Introduced in House

    IntroReferralLibrary of Congress
  17. Introduced in House

    IntroReferralLibrary of Congress
  18. Referred to the House Committee on Energy and Commerce.

    IntroReferralHouse floor actions

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 10, 2026 · Complete sponsorship check pending · Topics checked Oct 10, 2026 · Committees checked Oct 10, 2026 · Status checked Oct 10, 2026 · Related bills checked Oct 10, 2026.